Status:
COMPLETED
Patient Blood Management Program in Total Hip or Total Knee Arthroplasty
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Knee Arthropathy
Hip Arthropathy
Eligibility:
All Genders
18+ years
Brief Summary
Total hip and knee arthroplasty are among the most common surgical procedures for which blood transfusion is prescribed. Patient blood management program has been proposed to decrease the need for tra...
Detailed Description
This is a post-hoc analysis using part of the patients involved in the Cross Iron Study (Anesthesiology. 2018 Oct;129(4):710-720 ) Included patients were all the patients scheduled for elective primar...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patient from the flow chart of the Cross Iron Study (Anesthesiology. 2018 Oct;129(4):710-720 )
- patient scheduled for elective primary total hip or knee arthroplasty
- Exclusion criteria:
- pregnancy patient,
- patient under 18 years old
- systemic infection
- bilateral arthroplasty
- revision arthroplasty,
- participation in a preoperative autologous donation program.
Exclusion
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
723 Patients enrolled
Trial Details
Trial ID
NCT04137484
Start Date
July 1 2014
End Date
August 1 2016
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295